Release of ROS has the ability to inhibit myeloid derived suppressor cell (MDSC) maturation, known to suppress immune responses against tumors by releasing IL-10 [116], and induce cell death of tumor cells in the established tumor [117]. The gene discussed is IL10; the disease is neoplasm.